Three years after starting the defective drug, your medical bills total $62,000. Your New Hampshire class action settlement? Still years away. The pharmaceutical company’s initial offer through their settlement administrator? $45,000 for tier three placement.
They’re counting on your financial desperation to accept inadequate compensation that doesn’t cover your actual damages. New Hampshire personal injury pre-settlement funding from Pegasus Legal Funding can help you keep fighting.
Insurance companies and pharmaceutical manufacturers use financial pressure as their most effective settlement strategy. Our New Hampshire class action lawsuit pre-settlement funding removes their leverage entirely. See if your case qualifies by calling our case evaluators now.
How Pharmaceutical Companies Use Financial Pressure in Mass Tort Cases
Pharmaceutical companies and medical device manufacturers in class action lawsuits use sophisticated financial pressure tactics against individual plaintiffs. New Hampshire pre-settlement funding stops many of these by providing immediate financial resources while you wait for fair compensation.
Medical bills for treating complications began accumulating before you even knew you had a viable legal claim. But fair settlement? The pharmaceutical company’s lawyers ensure that it won’t arrive for years while they fight the case.
Every month you struggle financially increases the pressure to accept their inadequate offers rather than fight for the compensation your medical evidence actually supports. When your savings account hits zero, when collection agencies call daily, when foreclosure notices arrive, Pegasus Legal Funding can help.
Schedule your free consultation today 855-386-3968
The True Cost of Accepting Early Lowball Offers Under Financial Pressure
Class action participants who accept early settlement offers driven by financial desperation typically lose much of their case’s true value. The pharmaceutical company offered you $45,000 for a tier three placement. Your attorney says your medical documentation supports tier one compensation of $180,000 to $250,000. That’s a $135,000 to $205,000 difference.
Your case strength justifies tier one compensation. But none of that matters if you’re facing eviction next month and the pharmaceutical company’s settlement administrator offers immediate payment to accept tier three classification. Pre-settlement funding changes this calculation completely.
You receive a cash advance based on your expected tier one settlement value, use it to cover immediate financial needs, and only repay if your settlement materializes. Our class action lawsuit pre-settlement funding in New Hampshire is non-recourse, so we can only get paid back through your settlement or judgment.
How Funding Changes Your Negotiating Position Against Corporate Defendants
When you accept non-recourse pre-settlement funding, you eliminate the pharmaceutical company’s primary leverage over settlement negotiations. You can cover medical treatment costs, maintain housing, pay essential expenses, and preserve financial stability while your attorney pursues maximum case value.
Class action defendants often have huge legal resources and aggressive defense strategies. They know exactly how long most plaintiffs can survive financially before accepting whatever settlement they offer. Three months? Six months? Eighteen months? They calculate your breaking point and structure their settlement offers accordingly.
Pegasus Legal Capital provides you with the financial breathing room to pursue justice rather than accept quick settlements driven by financial pressure.
Click to contact us today
What Happens to Your Funding If You Accept a
Pre-settlement funding provides flexibility throughout your class action litigation. If pharmaceutical companies offer fair compensation earlier than expected, you repay the advance from your settlement proceeds and keep the remaining amount. If tier placement results in lower compensation than projected, you repay only what you actually receive, nothing more.
Your attorney negotiates with full knowledge of the funding arrangement. Settlement decisions remain entirely under your and your attorney’s control. If the pharmaceutical company suddenly offers a fair settlement, you can accept it, repay the advance plus fees from settlement proceeds, and receive the remaining funds.
If you’re excluded entirely, you owe nothing. The non-recourse structure protects you at every outcome level while removing the financial pressure that forces acceptance of inadequate offers.
Your pre-settlement funding consultation is free — contact us today!
Understanding Non-Recourse Protection During Uncertain Litigation
Class action outcomes remain uncertain throughout the years of MDL proceedings. Bellwether trials can fail, expert testimony can be excluded, and summary judgment can eliminate entire groups of claims.
Traditional loans would require repayment regardless of these adverse outcomes. Pre-settlement funding protects you from debt obligations if your case doesn’t produce the expected settlement.
If litigation produces outcomes worse than projections—lower-tier placement, settlement exclusion, case dismissal—you don’t face debt collection for the difference. That’s the biggest thing that sets us apart from traditional lenders.
See if Your Case Qualifies for New Hampshire Class Action Lawsuit Pre-Settlement Funding
Pegasus Legal Capital has provided non-recourse class action lawsuit pre-settlement funding in New Hampshire since 2008, and we’ve served class action participants and personal injury plaintiffs nationwide. We’ve funded over $500 million to more than 15,000 clients.
Our direct lender status eliminates broker fees, and our membership in the American Legal Finance Association reflects our commitment to ethical funding practices. Contact Pegasus Legal Capital today to learn how non-recourse funding can protect your ability to pursue fair compensation.
Your pre-settlement funding consultation is free — contact us today!